[Structural and functional changes of heart and vessels in patients with essential hypertension and type 2 diabetes]

A Belovol1, A Shalimova1, M Kochueva1

  • 1Kharkiv National Medical University; Kharkiv Medical Academy of Postgraduate Education, Ukraine.

Georgian Medical News
|April 19, 2014
PubMed

Insights

Essential hypertension and type 2 diabetes accelerate cardiovascular complications. Oxidative stress and endothelial dysfunction are key factors, leading to heart and vessel changes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathophysiology

Background:

  • Comorbidity of essential hypertension and type 2 diabetes leads to early target organ damage and cardiovascular complications.
  • Shared pathogenetic mechanisms, including insulin resistance and oxidative stress, drive disease progression.
  • Cardiovascular diseases are increasingly understood to involve free radical damage and endothelial dysfunction.

Purpose of the Study:

  • To investigate structural and functional changes in the heart and vessels.
  • To assess pro-oxidant and antioxidant status.
  • To measure proinflammatory cytokine levels in patients with essential hypertension and type 2 diabetes.

Main Methods:

  • Examined 102 patients with essential hypertension stage II and type 2 diabetes.
  • Assessed cardiohemodynamics, including left ventricular function and diastolic dysfunction.
  • Measured intima-media thickness, pulse wave velocity, and endothelium-dependent vasodilation.
  • Analyzed pro-oxidant/antioxidant status and proinflammatory cytokine levels.

Main Results:

  • Preserved left ventricular systolic function with predominant concentric hypertrophy and diastolic dysfunction (disordered relaxation).
  • Increased intima-media thickness and pulse wave velocity in carotid artery and aorta, with reduced endothelium-dependent vasodilation.
  • Elevated proinflammatory cytokines, activated pro-oxidant system, and suppressed antioxidant system.

Conclusions:

  • Structural and functional changes in the heart and major vessels are linked to increased cytokines and imbalanced redox status.
  • Oxidative stress and endothelial dysfunction play significant roles in the progression of cardiovascular complications in this patient group.
  • Understanding these mechanisms can inform targeted therapeutic strategies for comorbid hypertension and diabetes.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K